Incidence, Risk Factors, and Modified Risk Assessment Model of Venous Thromboembolism in Non‐Hodgkin Lymphoma Patients
2024

Risk Factors and Assessment of Blood Clots in Non-Hodgkin Lymphoma Patients

Sample size: 325 publication 10 minutes Evidence: moderate

Author Information

Author(s): Wen Li, Liu Rui, Shen Ying, Gao GongZhizi, Yang Rui, Wang Yiwen, Yang Ruoyu, Lin Zujie, Dong Ruijun, Zhao Wanhong, He Aili, Bai Ju

Primary Institution: The Second Affiliated Hospital of Xi'an Jiaotong University

Hypothesis

What are the characteristics and predictive risk factors for venous thromboembolism (VTE) in newly diagnosed non-Hodgkin lymphoma patients?

Conclusion

The study identified independent risk factors for VTE in NHL patients and proposed a modified risk assessment model that effectively predicts VTE risk.

Supporting Evidence

  • VTE developed in 7.09% of NHL patients.
  • Independent risk factors for VTE included clinical Stage III/IV, mediastinal involvement, history of VTE, D-dimer≥ 1345 μg/dL, and platelet (PLT)≥ 298 × 109.
  • The ThroLy score was improved by adjusting the hemoglobin cutoff and combining it with D-dimer testing.
  • Sequential testing of TM and TAT achieved a sensitivity of 66.7%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 96.7%.

Takeaway

This study found that some patients with non-Hodgkin lymphoma are at risk of developing blood clots, and it created a better way to predict who might get them.

Methodology

Data were collected from newly diagnosed NHL patients to analyze characteristics and potential predictive risk factors for VTE, and the clinical applicability of existing risk assessment models was evaluated.

Potential Biases

Potential biases may arise from the retrospective design and the specific clinical setting of the study.

Limitations

The study's findings may not be generalizable due to the specific patient population and the retrospective nature of the data collection.

Participant Demographics

The cohort comprised 325 NHL patients, with 51.7% male and 52.6% over 60 years old.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI: 0.528–0.750

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1002/cam4.70510

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication